Nuogen Pharma’s mission is to deliver the first FDA-approved anti-itch medication for chronic pruritus of unknown origin (CPUO) and other chronic itch conditions.
Duke Leahey
Advertisement
Articles by Duke Leahey
Advertisement
Latest Updated Articles
Nuogen Pharma: Innovation in the fight against itchMarch 30th 2020
Advertisement
Advertisement
Trending on Dermatology Times
1
How Emerging Androgenetic Alopecia Therapies Target DHT at the Scalp Level
2
Social Media Mythbusters: Beef Tallow
3
Dermatology Times Inaugural NP/PA Connect Cutaneous Oncology Workshop Kicks Off in Tampa
4
The Value of Clinician Collaboration for Skin Cancer Care
5